Advisor Group’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Advisor Group’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	33	–	–	﹤0.01%	5649
2019 Q3	$0	Hold	33	–	–	﹤0.01%	5607
2019 Q2	$0	Sell	33 -50	-60%	-$46	﹤0.01%	5552
2019 Q1	$0	Hold	83	–	–	﹤0.01%	5508
2018 Q4	$0	Hold	83	–	–	﹤0.01%	5448
2018 Q3	$0	Sell	83 -467	-85%	-$1.16K	﹤0.01%	5402
2018 Q2	$2K	Hold	550	–	–	﹤0.01%	4750
2018 Q1	$2K	Hold	550	–	–	﹤0.01%	4767
2017 Q4	$1K	Hold	550	–	–	﹤0.01%	4921
2017 Q3	$2K	Sell	550 -6	-1%	-$20	﹤0.01%	4628
2017 Q2	$2K	Buy	556 +6	+1%	+$23	﹤0.01%	4583
2017 Q1	$2K	Hold	550	–	–	﹤0.01%	4476
2016 Q4	$2K	Hold	550	–	–	﹤0.01%	4306
2016 Q3	$2K	Hold	550	–	–	﹤0.01%	4258
2016 Q2	$1K	Buy	+550	New	+$2.52K	﹤0.01%	4360

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advisor Group's CTIC Position: Q4 2019 in Review

Advisor Group held its CTI BioPharma Corp. (DE) Common Stock (CTIC) position steady in Q4 2019 at 33 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5649.

Advisor Group first reported a position in CTIC in Q2 2016 and has held it in 15 quarters since. The position peaked at $2K in Q2 2018. 40 funds tracked by Wall St. Rank hold CTIC as of Q4 2019.

Advisor Group held 33 shares of CTI BioPharma Corp. (DE) Common Stock worth $0 as of Q4 2019.
Advisor Group left its CTI BioPharma Corp. (DE) Common Stock share count unchanged in Q4 2019.
CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5649 holding.
Advisor Group first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2016 and has held it in 15 quarters since.
Advisor Group's CTI BioPharma Corp. (DE) Common Stock position peaked at $2K in Q2 2018.
40 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.